MRNA - Latest News
Moderna, Inc. (MRNA), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $25.12B. Beta to the broader market is 0.90.
The article list below shows the most recent MRNA headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent MRNA Headlines
Moderna, Inc. $MRNA Shares Acquired by Contravisory Investment Management Inc.
defenseworld.net - Aug 10, 2026
Contravisory Investment Management Inc. increased its position in shares of Moderna, Inc.
Moderna Q2 Earnings Call Highlights Cost Cuts and Pipeline Milestones
zacks.com - Aug 7, 2026
MRNA keeps its 2026 growth target intact while cutting cost guidance and advancing flu, oncology and rare-disease programs toward key milestones.
These New Drugs Could Fuel Fresh Highs for Biotech and Pharma Stocks
barrons.com - Aug 7, 2026
Positive readouts in cancer and cardiac drug trials could keep the rally going. Sizing up the stakes for Merck, Moderna, Summit Therapeutics, and mor
This new kind of flu shot by Moderna has just been approved by the FDA
fastcompany.com - Aug 6, 2026
The Food and Drug Administration has approved a new kind of flu vaccine for older people, the first made with the same mRNA technology that was key to
Moderna Stock Flashing Intriguing ‘Buy The Dip' Signal
forbes.com - Aug 6, 2026
Moderna (MRNA) stock made a name for itself during the height of the pandemic, trading as high as $497 five years ago in 2021. Now, shares of the dru
How News Affects MRNA Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track MRNA's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked MRNA news questions
- What is the latest MRNA news headline?
- The most recent MRNA headline (Aug 10, 2026) is "Moderna, Inc. $MRNA Shares Acquired by Contravisory Investment Management Inc.". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the MRNA news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What MRNA news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual MRNA options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.